FDANonrulemakingFDA-2026-N-4162

Who commented on this docket

Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments - Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA) manufactured by Moderna TX Inc.

5 organizations filed 5 public comments on Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments - Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA) manufactured by Moderna TX Inc., at the Food and Drug Administration. The comment window closed 95d ago.

Organizations
5
Comments
5
RIN
Comment window
closed 95d ago

Abstract

OPEN

Commenters (5)

  • Adult Vaccine Access Coalitiontrade assoc.
    1 filing · confidence 85%
  • Alliance for mRNA Medicinestrade assoc.
    1 filing · confidence 85%
  • Infectious Diseases Society of Americatrade assoc.
    1 filing · confidence 85%
  • Vasculitis Foundationtrade assoc.
    1 filing · confidence 85%
View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.